Vext Science, Inc.
VEXTF
$0.20
$0.014.32%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 32.67% | 42.69% | 39.78% | 32.45% | 14.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.67% | 42.69% | 39.78% | 32.45% | 14.89% |
| Cost of Revenue | 17.23% | 36.68% | 35.60% | 19.87% | 15.00% |
| Gross Profit | 78.09% | 60.74% | 52.00% | 75.39% | 14.57% |
| SG&A Expenses | 13.60% | 9.64% | -8.86% | -7.24% | 8.03% |
| Depreciation & Amortization | 11.32% | -4.56% | -36.40% | -34.93% | -25.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.52% | 23.35% | 9.04% | 2.29% | 6.78% |
| Operating Income | 51.84% | 38.91% | 56.95% | 59.14% | 16.40% |
| Income Before Tax | 31.67% | 27.95% | -123.13% | -114.85% | -702.60% |
| Income Tax Expenses | 127.25% | 111.65% | 105.45% | 323.67% | 708.42% |
| Earnings from Continuing Operations | 19.96% | 19.78% | -119.40% | -138.31% | -867.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.96% | 19.78% | -119.40% | -138.31% | -867.88% |
| EBIT | 51.84% | 38.91% | 56.95% | 59.14% | 16.40% |
| EBITDA | 125.32% | 158.28% | 538.93% | 328.50% | 675.24% |
| EPS Basic | 20.30% | 22.16% | -129.69% | -113.06% | -695.96% |
| Normalized Basic EPS | 55.48% | 43.31% | 27.97% | 35.44% | -2.24% |
| EPS Diluted | 15.10% | 19.41% | -128.53% | -112.91% | -567.80% |
| Normalized Diluted EPS | 55.38% | 43.19% | 27.67% | 35.50% | -2.25% |
| Average Basic Shares Outstanding | 0.47% | 2.78% | 7.01% | 19.12% | 34.37% |
| Average Diluted Shares Outstanding | 0.15% | 2.43% | 6.51% | 19.31% | 34.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |